Shanghai Henlius Biotech, Inc. (HKG:2696)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biopharmaceutical	6.21B
Biopharmaceutical Growth	4.11%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	5.47B
China Growth	2.92%
North America	356.84M
North America Growth	2.59%
Asia Pacific	256.81M
Asia Pacific Growth	19.81%
Europe	109.95M
Europe Growth	76.53%
South America	11.52M
South America Growth	-45.55%
Oceania	352.37K